China Dental Soft Tissue Regeneration Market Size & Outlook, 2026-2034
China Dental Soft Tissue Regeneration Market Insights
- As per Reed Intelligence insights, the China Dental Soft Tissue Regeneration Market stood at USD 105.36 Million in 2025 and is anticipated to grow to USD 264.69 Million by 2034.
- The China market is expected to advance at a CAGR of 10.76% from 2026 through 2034.
- In 2025, Soft Tissue Grafts accounted for the highest share of the Product Type market size.
- During the forecast period, Soft Tissue Grafts is set to register the highest growth, making it the most lucrative Product Type segment.
![China Dental Soft Tissue Regeneration Market Size, Share & Growth Analysis By [2034]](https://reedintelligence.com/uploads/charts/china-dental-soft-tissue-regeneration-market-china-product-type-156373.png)
Source: RI Analysis Company Publications, Primary Interviews.
Other Key Findings
- In 2025, China accounted for 7.42% of the global Dental Soft Tissue Regeneration Market size.
- By 2034, United States is expected to lead the global Dental Soft Tissue Regeneration Market in terms of market size.
- Within Asia Pacific, China is projected to dominate the regional Dental Soft Tissue Regeneration Market size by 2034.
- South Korea is identified as the fastest-growing market in Asia Pacific, anticipated to reach USD 37.96 Million by 2034.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2025 |
| Study Period | 2022-2034 |
| Historical Period | 2022-2024 |
| Forecast Period | 2026-2034 |
| Market Size In 2025 | USD 105.36 Million |
| Market Size In 2034 | USD 264.69 Million |
| Largest segment | Soft Tissue Grafts |
| Units | Revenue in USD Million |
| CAGR | 10.76% (2026-2034) |
| Segmnetation Covered | |
| Product Type |
|
| Application |
|
| End Use |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
China Dental Soft Tissue Regeneration Market Product Type 2026-2034 (USD Million)
| Product Type | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Soft Tissue Grafts | XX.x | XX.x | XX.x | 40.29 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Biologic Regenerative Materials | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Collagen Membranes | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Tissue Engineering Scaffolds | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Xenografts and Allografts | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
China Dental Soft Tissue Regeneration Market Application 2026-2034 (USD Million)
| Application | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Periodontal Regeneration | XX.x | XX.x | XX.x | 37.12 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Implant Tissue Support | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Gum Recession Treatment | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Ridge Augmentation | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Cosmetic Gum Reconstruction | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
China Dental Soft Tissue Regeneration Market End Use 2026-2034 (USD Million)
| End Use | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dental Clinics | XX.x | XX.x | XX.x | 42.47 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Hospitals | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Ambulatory Surgical Centers | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Academic and Research Institutes | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.